Immunic Shares Are Trading Higher After Brookline Capital Initiated Coverage on the Stock With a Buy Rating and a Price Target of $10
在布魯克林資本開始對該股進行保險後,Immunic股價走高,評級爲買入,目標股價爲10美元
Immunic Shares Are Trading Higher After Brookline Capital Initiated Coverage on the Stock With a Buy Rating and a Price Target of $10
在布魯克林資本開始對該股進行保險後,Immunic股價走高,評級爲買入,目標股價爲10美元
使用瀏覽器的分享功能,分享給你的好友吧